Literature DB >> 26424354

Off-label targeted cancer drugs fail in first randomized trial.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26424354     DOI： 10.1038/nrd4758

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.

Authors:  Ya Zhang; Xuefeng Wu; Yan Kai; Chia-Han Lee; Fengdong Cheng; Yixuan Li; Yongbao Zhuang; Javid Ghaemmaghami; Kun-Han Chuang; Zhuo Liu; Yunxiao Meng; Meghana Keswani; Nancy R Gough; Xiaojun Wu; Wenge Zhu; Alexandros Tzatsos; Weiqun Peng; Edward Seto; Eduardo M Sotomayor; Xiaoyan Zheng
Journal:  JCI Insight       Date:  2019-12-19

Review 2.  Tissue-specific tumorigenesis: context matters.

Authors:  Günter Schneider; Marc Schmidt-Supprian; Roland Rad; Dieter Saur
Journal:  Nat Rev Cancer       Date:  2017-03-03       Impact factor: 60.716

Review 3.  Understanding flow chemistry for the production of active pharmaceutical ingredients.

Authors:  Anand S Burange; Sameh M Osman; Rafael Luque
Journal:  iScience       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.